Effectiveness of new iron polyacrylate preparation in treatment of anemia associated with iron deficiency

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/4726

Full metadata record

DC Field	Value	Language
dc.contributor.author	Toshev Jalol Хakimovish, Babadjanova Shoira Agzamovna, Kurbоnova Zumrad Chutbaevna	-
dc.date.accessioned	2022-12-03T05:42:44Z	-
dc.date.available	2022-12-03T05:42:44Z	-
dc.date.issued	2021-06	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/4726	-
dc.description.abstract	After the introduction of iron polyacrelate in the main 2 groups there was an increase in Hb 14.5 ± 1 g / l, erythrocytes 4.5±0.3 x1012/l, reticulocytes 9.6%. Similar changes were found in the control group. The iron polyacrelate was found to be as effective as the hemolyph drug. The drug did not change liver activity, i.e. ALT, AST, total bilirubin practically did not change.	en_US
dc.language.iso	en	en_US
dc.publisher	Italy	en_US
dc.subject	Hb,erythrocytes,reticulocytes,iron,ALT, AST, total bilirubin	en_US
dc.title	Effectiveness of new iron polyacrylate preparation in treatment of anemia associated with iron deficiency	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
2021 ITALY EFFECTIVENESS OF NEW IRON POLYACRYLATE.pdf		1.32 MB	Adobe PDF	View/Open

DSpace JSPUI